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Abstract
Mapping the molecular composition of individual excitatory synapses across the mouse 
brain reveals high synapse diversity with each brain region showing a distinct 
composition of synapse types. As a first step toward systematic mapping of synapse 
diversity across the human brain, we have labelled and imaged synapses expressing the 
excitatory synapse protein PSD95 in twenty human brain regions, including 13 
neocortical, two subcortical, one hippocampal, one cerebellar and three brainstem 
regions, in four phenotypically normal individuals. We quantified the number, size and 
intensity of individual synaptic puncta and compared their regional distributions. We 
found that each region showed a distinct signature of synaptic puncta parameters. 
Comparison of brain regions showed that cortical and hippocampal structures are similar, 
and distinct from those of cerebellum and brainstem. Comparison of synapse parameters 
from human and mouse brain revealed conservation of parameters, hierarchical 
organization of brain regions and network architecture. This work illustrates the feasibility 
of generating a systematic single-synapse resolution atlas of the human brain, a 
potentially significant resource in studies of brain health and disease.
KEYWORDS
Postsynaptic density protein 95, PSD-95, human post-mortem brain tissue, regional 
diversity, synaptome mapping, synaptome atlas, automated image analysis
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Introduction
The vast majority of interactions between nerve cells occur at synapses. The spatial 
location and the molecular composition of the pre- and postsynaptic elements are 
important factors in their cellular function. More than half a century of anatomical, 
physiological and molecular research has established that synapses integrate the 
information that is inherent in patterns of neuronal activity that lead to output, i.e. 
behavior. The postsynaptic elements of synapses are particularly interesting because 
they host multiprotein signalling complexes that link together neurotransmitter receptors, 
ion channels, signalling enzymes, adhesion and structural proteins, thus supporting 
signal integration and intracellular signalling (Migaud et al., 1998; Husi et al., 2000; 
Komiyama et al., 2002; Collins et al., 2006; Fernandez et al., 2009; Fernandez et al., 
2017).
A key component of these complexes is the scaffold protein PSD95, one of the most 
abundant synaptic proteins in the brain (Cho et al., 1992; Frank et al., 2016; Frank & 
Grant, 2017; Frank et al., 2017). The complexes formed by PSD95 have been 
extensively studied in vivo and shown to play a key role in short- and long-term synaptic 
plasticity and many innate and learned behaviours (Migaud et al., 1998; Komiyama et al., 
2002; Fagiolini et al., 2003; Opazo et al., 2003; Carlisle et al., 2008; Abbas et al., 2009; 
Feyder et al., 2010; Camp et al., 2011; Nithianantharajah et al., 2013; Ryan et al., 2013; 
Fitzgerald et al., 2015; van de Lagemaat et al., 2017). Importantly, PSD95 mutations in 
humans cause intellectual disability (Lelieveld et al., 2016; Moutton et al., 2018) and 
mutations in the proteins within PSD95 complexes are responsible for dozens of 
neurological and psychiatric diseases including schizophrenia and autism (Husi et al., 
2000; Grant et al., 2005; Pocklington et al., 2006; Fernandez et al., 2009; Feyder et al., 
2010; Bayes et al., 2011; Fromer et al., 2014; Purcell et al., 2014; Fernandez et al., 
2017). 
Mammalian synapses contain thousands of evolutionarily conserved proteins (Bayes et 
al., 2011; Bayes et al., 2012; Bayes et al., 2017) and these are differentially distributed in 
brain regions (Emes et al., 2008; Hawrylycz et al., 2012; Roy et al., 2018a; Roy et al., 
2018b). Vizualization of proteins at the individual synapse level reveals a far greater A
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synapse diversity than could be anticipated from historical studies of synapse 
morphology, neurotransmitters and physiology (Micheva et al., 2010; O'Rourke et al., 
2012; Zhu et al., 2018). Driven by the ability to systematically characterize the molecular 
composition of individual synapses across the whole brain, the term ‘synaptome’ has 
been introduced to describe the catalogue of synapses in the brain or part thereof 
(Micheva et al., 2010; O'Rourke et al., 2012; Zhu et al., 2018). 
We recently systematically examined the distribution of PSD95 and SAP102 (another 
postsynaptic scaffold protein in excitatory synapses) at single-synapse resolution in 
hundreds of subregions within twelve main regions of the adult mouse brain (Zhu et al., 
2018). PSD95 and SAP102 were fluorescently labelled and tissue sections imaged with 
confocal microscopy; then, sophisticated image analysis tools exploiting computer vision 
and machine-learning were used to detect individual synapses and measure their 
molecular and morphological properties, classifying the synapses and mapping their 
spatial locations. Each brain region had a characteristic ‘signature’ of PSD95-positive or 
SAP102-positive synapses, and synapses expressing both proteins had yet another map. 
When these molecular types of synapses were further subcategorized using data on 
synapse size, shape and intensity of labelling, it was possible to build a larger catalogue 
and show that each synapse subtype had a unique synaptome map. A striking feature of 
all these maps is that they reveal a 3D spatial architecture to the synaptic organization of 
the brain, termed the ‘synaptome architecture’ (Zhu et al., 2018). We showed that 
synaptome architecture has the potential to store behavioural representations and was 
correlated with the structural and functional connectome. Mutations in Dlg3 and Dlg2, 
which cause intellectual disability and schizophrenia in humans, respectively, caused a 
change in the PSD95 synaptome architecture, suggesting that synaptic diseases 
manifest with altered spatial distribution of excitatory synapse types (Zhu et al., 2018; 
Grant, 2019).
Understanding synapse diversity and synaptome architecture in the human brain will 
inform on many key issues in both basic neuroscience and neurological disease 
research, from how and when gene mutations exert their effects on particular synapses 
and circuits to whether the synaptome architecture of the mouse and human show A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
conservation. As a first step toward creating a human synaptome atlas, we recognized 
the need to overcome several technical challenges. First, the need to develop robust 
molecular labelling of excitatory synapses in post-mortem brain tissue using 
immunohistochemistry (IHC) suitable for analysis with the SYNMAP pipeline developed 
for the mouse brain (Zhu et al., 2018). To optimize and validate our IHC labelling of 
PSD95, we took advantage of two lines of genetically modified mice that we had 
previously characterized: mice lacking PSD95 (Psd95–/–) (Migaud et al., 1998) and mice 
expressing PSD95 fused to green fluorescent protein (PSD95eGFP) (Zhu et al., 2018). 
Psd95–/– and PSD95eGFP mice serve as negative and positive controls, respectively, for 
antibody staining. Second, given that the human brain is 1000-fold larger than that of the 
mouse, we needed to explore the feasibility of acquiring single-synapse resolution data 
across the major brain regions. Although PSD95 immunostaining has been reported in 
specific human brain regions, including frontal cortex, caudate nucleus, putamen and 
hippocampus (Glantz et al., 2007; Fourie et al., 2014; Morigaki & Goto, 2015), there is no 
single comprehensive study of PSD95 distribution across a number of human brain areas 
at single-synapse resolution using a high-throughput quantitative analysis.
Here we report a detailed qualitative and quantitative survey of the distribution and 
diversity of PSD95-labelled synapses throughout 20 human brain areas from four 
phenotypically normal individuals. We describe the PSD95 synaptome architecture of 
these human brain regions and analyze regional similarity within the human brain and 
between human and mouse brain. We discuss the utility of this dataset for studies of the 
normal and diseased brain and the logistical considerations for large-scale human 
synaptome mapping.
Materials and methods
Consent
Post-mortem human brain tissue was obtained from the Medical Research Council UK 
(MRC) funded University of Edinburgh Brain Bank (EBB). All procedures involving post-
mortem human brain tissue were approved by East of Scotland Research Ethics Service 
(16/ES/0084). Informed written consent was obtained in relation to each subject.A
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Human subjects
Human brains from four control subjects (three males, one female; mean age 51 ± 6.9 
(standard deviation) years) were used to image PSD95 using laser scanning confocal 
microscopy (LSCM). Details of the human subjects are listed in Table 1. None of the 
control subjects had a history of dementia, neurological or psychiatric disorders at the 
time of death. Human brain tissue donated to the EBB was processed according to 
departmental protocols. Briefly, formalin-fixed paraffin-embedded (FFPE) 4 μm tissue 
sections were stained with hematoxylin and eosin (H&E) for routine neuroanatomical and 
neuropathological surveys. Selected sections were stained with a panel of antibodies that 
detect phosphorylated tau for neuronal and glial inclusions, beta-amyloid for vascular and 
parenchymal amyloid deposition, ubiquitin for ubiquitinated aggregates and/or alpha-
synuclein for Lewy body pathology. Gross anatomical and microscopic examinations of 
the brain tissue revealed only low age-related neuropathological changes in these control 
brains (Table 2). 
Post-mortem procedures
At post-mortem examination brains were macroscopically dissected into 1 cm-thick 
coronal slices and sampled according to the EBB protocol (Samarasekera et al., 2013). 
Small tissue blocks were immediately fixed in 10% formaldehyde for 24-72 h prior to 
further tissue processing and embedding in paraffin wax. The blocks were sampled from 
13 neocortical areas (six frontal, four temporal, one parietal, two occipital), one 
allocortical area (hippocampus), two subcortical grey matter areas (thalamus and 
caudate nucleus) and four infratentorial regions (midbrain, pons, medulla and cerebellum) 
(Table 3). The 13 neocortical areas are defined as Brodmann areas (BAs), and include 
sensory visual regions (BA17 and BA19), sensory auditory region (BA41/42), motor 
region (BA4), premotor region (BA6/8), associative frontal regions (dorsolateral BA9 and 
BA46, ventrolateral BA44/45, and orbital BA11/12), associative temporal regions 
(BA20/21 and BA38), associative parietal region (BA39) and associative occipitotemporal 
region (BA37). The pathological changes in neurodegenerative diseases are present 
throughout the brain parenchyma; however, careful selection of representative areas 
allows efficient screening of tissue for any potential disease entities (King et al., 2013). 
The choice of the anatomical regions examined was additionally guided by the availability A
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of all 20 blocks for the four control cases. Tissue blocks were macroscopically dissected 
by experienced pathologists and the selection of blocks closely followed topographical 
brain anatomy using the patterns of sulci and gyri. Regions of interest were further 
identified using an atlas of the human brain (Mai et al., 2015). Nissl-stained sections from 
blocks immediately adjacent (where possible) to those used for IHC were examined to 
assess and confirm the distinctive cytoarchitectural features of various areas. The 
absence of significant neuropathological findings was further confirmed by routine 
examination of immunohistochemical and special stains available from the Department of 
Academic Neuropathology, Edinburgh University. 
Fluorescence immunohistochemistry
FFPE human brain sections (4 μm thick) were dewaxed and dehydrated as per the EBB 
neuropathology laboratory protocol. Briefly, sections were dewaxed in two 3-min xylene 
washes followed by four 3-min graded alcohol washes, comprising two 74°OP (IMS99%) 
alcohol washes and two 70% alcohol washes. This was followed by a 15-min wash in 
saturated alcoholic picric acid to remove any formalin sedimentation and a final wash in 
running tap water for 15 min. Antigen and heat retrieval techniques were used to 
enhance cell surface staining, antigen detection from antigen-masked FFPE sections and 
reduction of non-specific background staining. The slides were placed in 250 ml freshly 
made antigen retrieval solution (0.1 M sodium citrate buffer pH 6.0, Fisher Scientific) and 
pressure cooked (A. Menarini Diagnostics) at 125°C for 30 s. After cooling in tap water, 
sections were washed once with PBS and blocked with 5% bovine serum albumin (BSA, 
Sigma-Aldrich) in 1x Tris-buffered saline (TBS, Fisher BioReagents) containing 0.2% 
Triton X-100 (Sigma-Aldrich) for 1 h at room temperature (RT). Sections were then 
incubated overnight at 4°C with primary antibodies: PSD95 (IgG2a, mAb, K28/43, 1:250; 
NeuroMab), Synapsin1 (IgG, mAb, 13197S, 1:200; Cell Signaling), Synaptophysin (IgG, 
mAb, SP11, RM-9111, 1:200; Thermo), Calbindin D-28K (IgG, pAb, CB38, 1:50; Swant) 
diluted in TBS containing 3% BSA and 0.2% Triton X-100. After three 5-min washes with 
TBS and 0.2% Triton X-100, secondary antibodies (Alexa Fluor 546 goat anti-mouse 
IgG2a (γ2a) (Molecular Probes) for PSD95; Alexa Fluor 633 (Molecular Probes) for 
synaptophysin or synapsin 1) were added at 1:500 and sections incubated for 2 h at RT. 
Each IHC staining round was accompanied by nuclear cell counterstaining with 4',6-A
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diamidino-2-phenylindole (1μg/ml DAPI (Sigma) diluted 1:1000 in PBS). Finally, the 
slides were washed three times with TBS and 0.2% Triton X-100. For elimination or 
reduction of lipofuscin-like autofluorescence, sections were subsequently treated with 
Autofluorescence Eliminator Reagent (AER, Millipore Chemicon International). Lipofuscin 
pigment accumulates in the cytoplasm of brain cells and can hamper fluorescence 
microscopy owing to its broad excitation and emission spectra. AER is a commercially 
available Sudan Black (SB)-based reagent that has been successfully used in studies 
using human tissue (Blazquez-Llorca et al., 2010). SB has been reported to provide the 
best compromise between the reduction of lipofuscin-like fluorescence and maintenance 
of specific fluorescent labels (Schnell et al., 1999). Briefly, the sections were first 
immersed in 70% ethanol for 5 min, followed by the AER for 30 s. Slides were washed in 
70% ethanol for a further 3 min before being mounted with mounting medium (Mowiol 
with 1,4-diazabicyclo[2.2.2]octane (DABCO), Sigma-Aldrich) and left to dry overnight. 
Validation of PSD95 IHC with PSD95eGFP mouse
Qualitative and quantitative comparisons with a selection of images from PSD95eGFP 
mice were made to validate the human PSD95 staining. At first, the representative IHC 
images of coronal sections from several mouse brain areas were acquired using the 
same LSCM and with the same parameter set-up. Then, a direct quantitative comparison 
of PSD95eGFP mouse versus human results was made for three wild-type (WT) male 
mice (aged 18 months) and three human male control subjects from ten brain regions. 
The PSD95eGFP mouse data were acquired with a spinning disk microscope and 
analysed using the ensemble analysis as previously described (Zhu et al., 2018). 
Image acquisition
To resolve individual synaptic puncta, antibody-labelled brain tissue sections were 
captured using a Zeiss laser scanning confocal microscope (LSCM510) using a Zeiss 
Plan-Apochromat 63x oil-immersion objective lens (NA 1.4) with a frame size of 1024 x 
1024 pixels, a pixel dimension of 46 x 46 nm and a depth of 8 bit. All raw images were 
obtained with x3.1 zoom as stacks of six image planes with z-step of 130 nm pixels and a 
total length of axial plane 780 nm pixels. The total area used for synaptic density 
determination varied depending on region, but for cortical areas 18 images, three images A
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per each of six cortical layers, per BA per subject were acquired. The images taken were 
of neuropil, and structures, such as blood vessels or cell bodies, were avoided when 
possible. A total of 1510 confocal images were acquired, of which 21 images (1.4%) were 
excluded due to technical problems, including too low signal-to-noise ratio precluding 
adequate image analysis, a lack of alignment in z-stacks, and images with overexposed 
synaptic puncta. Images and figure montages were prepared in Adobe Photoshop and 
Adobe Illustrator. Where necessary, images were adjusted for brightness for correct 
display, but no other corrections were made.
For the visualisation of the whole-mounted brain sections, a Zeiss Axio Scan.Z1 Slide 
Scanner with a 20x lens (NA 0.8) was used. Pixel resolution was 0.325 x 0.325 μm and 
image brightness was in a depth of 16 bits. ZEN lite 2012 software (Zeiss) was used with 
the scanner for image acquisition and adjustment. Coronal brain section images were 
background and contrast adjusted to provide consistent comparison of PSD95 
expression. All control images were directly comparable with their negative controls using 
the same settings. The slide scanner-captured images were used only for qualitative 
comparisons. The slide scanner was also used to capture Nissl-stained material for direct 
assessment of tissue integrity and cytoarchitecture of sections used in this study.
Image analysis 
Analysis of the human synapse images includes synaptic puncta detection, segmentation 
and parameter quantification. The detection and segmentation of individual puncta were 
performed by ensemble learning, a machine-learning approach developed in house (Zhu 
et al., 2018). Ensemble learning of image detection requires an annotated image set from 
the LSCM dataset for algorithm training. Raw tile images were first selected from the 
whole dataset using random bootstrapping. PSD95-labelled individual synaptic puncta in 
each of the images were then manually annotated using the Fiji plugin ‘Cell Counter’ 
(Schindelin et al., 2012) by two independent experts. Half of the annotated data were 
used for training and the other half for testing of the trained detector. A K folder strategy 
was also used for validation of the training. The second step in the ensemble image 
analysis involves algorithm training of the synaptic puncta detector, which is based on a 
multi-resolution image feature detection (Qiu et al., 2012) and supervised machine-A
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learning technique. A multi-resolution and multi-orientation version of 2nd-order nonlocal 
derivative (NLD) to calculate intensity differences, or image features, was developed for 
each of all individual puncta. For instance, for an image of PSD95 IHC, a group of 109 
feature images was calculated per punctum. These intensity differences were assembled 
as feature vectors of each individual punctum. Details of the algorithm training are 
provided in our previous work (Zhu et al., 2018). Once training was finished, the trained 
ensemble detector was applied to automatically detect puncta in the LSCM images. The 
detected object was then segmented by thresholding the pixel intensity of the puncta. 
The threshold was calculated adaptively for each punctum as 18% of the maximal 
intensity of the punctum after subtracting the background intensity. 
Different puncta parameters were measured after the detection and segmentation. In 
particular, the mean punctum intensity is a measurement of the relative amount of PSD95 
protein within the postsynaptic density (PSD), since the absolute number of PSD95 
molecules cannot be resolved using confocal imaging. Nevertheless, the mean punctum 
intensity provides a good insight into the differences in average packing of PSD95 
between areas or individuals. Puncta size is a measurement of the relative area of 
PSD95-positive synapses. It is calculated as the number of pixels within the segmented 
puncta and converted to μm2. The final measurement provided by ensemble image 
analysis is the puncta density, i.e. the number of detected puncta per 100 μm2.
Statistical analysis 
Three PSD95 punctum parameters, namely density (puncta number per 100 μm2), 
intensity (A.U.) and size (μm2), were used for the statistical study. The parameters were 
plotted with the Tukey-style as box and whisker plots (Krzywinski & Altman, 2014). 
Normality of LSCM data distribution was analyzed using the D’Agostino-Pearson 
omnibus normality test. For heatmap generation, the data were reorganized using an 
agglomerative hierarchical clustering algorithm and standardized using the z-score 
normalization. A similarity matrix in Figure 8A was generated to quantify the PSD95 
synaptome network architecture in the human brain. Each row/column in the matrix 
represents a brain region/subregion. The rows/columns are resorted to indicate the brain 
anatomy: anatomically close regions are placed in adjacent rows/column in the matrix. A
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The elements of the matrix are the similarity and calculated using the Euclidean 
distances of the three synaptic parameters between the two regions. It ranges from zero 
to one, the latter indicating an identical synaptome of the two regions. The similarity 
matrix was plotted as a heatmap where the elements were color coded.
Results
The study is divided into four phases: i) the optimization of synaptic labelling with 
antibodies to PSD95, ii) the systematic acquisition of image data from 20 brain regions 
with a detailed description of the synaptic anatomy, iii) an analysis of the populations of 
synapses in the brain areas, and iv) a comparison of the PSD95 synaptome architecture 
of human and mouse.
Optimization of PSD95 immunostaining
To identify optimal IHC conditions we used four complementary approaches. First, we 
used the standard IHC controls including the presence and absence of primary and 
secondary antibodies on human tissue (Figure S1). Strong punctate staining was 
observed with PSD95 antibodies and abolished when either primary or secondary 
antibodies were absent. Second, to confirm that the PSD95-positive puncta observed 
were synaptic, we labelled the excitatory presynaptic terminals with synapsin 1 and 
synaptophysin (Figure S2) (Koffie et al., 2009) and detected the characteristic juxtaposed 
labelling in 91.5% and 87.8% of synapses, respectively. Third, we performed PSD95 IHC 
on brain sections from Psd95 knockout mice and confirmed the absence of signal (Figure 
S3). Fourth, we compared the puncta distribution of multiple human brain regions with the 
corresponding regions in mice expressing PSD95eGFP, which revealed similar synaptic 
puncta distributions in these areas (Figure 1). We screened eight commercially available 
antibodies and found best results with anti-PSD95 monoclonal IgG2a (NeuroMab) at 16 
ng/ml (a 250-fold dilution of the 4 μg/ml stock solution).
Human brain regions show different distributions of excitatory synapses
In order to describe the distribution patterns of the PSD95-positive synapses in the 
human brain, we performed IHC on post-mortem material from 20 regions. 
Representative images from these selected brain areas are shown in Figure 2. PSD95 A
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expression was detected as fluorescent puncta (< 1 m in size) in all regions. In general, 
the PSD95 puncta appeared intense and densely packed in the neocortex and the 
hippocampus. However, even within the neocortex, different areas displayed unique 
combinations of bright, dim, large and small puncta. In the subcortical structures, the 
thalamus and caudate nucleus, the puncta tended to show moderate densities and 
intensities. A high density of intense PSD95 puncta was found in some parts of the 
cerebellum, such as the granular cell layer, but not others, such as the cerebellar white 
matter. Both the hippocampus and cerebellum showed distinct subregional distribution 
patterns of PSD95 puncta, as described below. Synaptic puncta density was low in all 
major areas of the brainstem examined (midbrain, pons and medulla). Synaptic puncta 
were almost absent from the cortical and the cerebellar white matter (not shown). Thus, 
human brain regions show diversity in the densities, intensities and size of PSD95 
puncta. In the following sections, we describe some of the diversity observed within the 
hippocampal formation, the deep grey nuclei (caudate and thalamus), cerebellum and 
brainstem.
In the human hippocampal formation, there was intense PSD95 staining within CA1-4 
subregions as well as the dentate gyrus (DG) (Figure 3A-C). The highest intensity of 
staining was seen in CA1 (Figure 3D-F). Bright PSD95 staining was mostly observed 
within the dendritic layers, including stratum radiatum and stratum lacunosum-moleculare 
(Figure 3G) as well as the molecular layer of the DG (Figure 3H, P). Staining was 
observed on the cell bodies of the pyramidal cells of the CA1-4 subregions (Figure 3I, J), 
in contrast to the granule cells of the DG that lacked staining (Figure 3K, L). CA1 
contained small bright PSD95 puncta (Figure 3M), whereas CA2 puncta were dimmer 
(Figure 3N). The puncta observed in the neuropil of the pyramidal cell layer of the CA3 
(not shown) and CA4 subregions (Figure 3O) appeared very similar in size, intensity and 
pattern of staining: they were large, moderately bright, and formed a rosette-like pattern 
of staining.
The caudate nucleus showed strong PSD95 labelling (Figure 4A-C), with small patches 
(Figure 4B asterisk) that we confirmed to be striosomes by IHC with Calbindin-D28K (Ito 
et al., 1992) (Figure 4D-F), which are embedded within the matrix. In addition to dendritic A
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staining, somatic staining was observed, presumably in medium spiny neurons. In the 
thalamus, moderate numbers of PSD95 puncta were detected (Figure 4G-I). PSD95 
puncta were often found lined up along neuronal dendrites (Figure 4J), although a more 
diffuse distribution of puncta was also seen.
In the cerebellum PSD95 staining was restricted to the cerebellar folia, absent from the 
white matter and present at low levels in the dentate nucleus (Figure 5A-C). The adult 
cerebellar cortex is a three-layer structure composed of an internal granular cell layer 
(GCL), Purkinje cell layer (PCL) organized into a single row of Purkinje cells (PCs), and a 
molecular cell layer (MCL), and the pattern of PSD95 distribution varied between these 
layers (Figure 5D, E). Overall, PSD95 staining was higher in the GCL than in the MCL, 
and no PSD95 staining was seen in the PCs (Figure 5D, E). Numerous and dense 
clusters of PSD95 puncta were dispersed throughout the glomerular region of the GCL 
between the granule cells (Figure 5D small arrowheads). PSD95 puncta were only 
detected in the terminal pinceau (also known as the presynaptic plexus) of cerebellar 
basket cells, surrounding the axon hillock regions of PCs, but the postsynaptic PC 
neurons did not express the protein (Figure 5D long arrowheads). A much lower density 
of PSD95 was detected within the neuropil of the MCL, where staining within the larger 
nuclei of the stellate and basket cells was observed (Figure 5D asterisks). Higher 
magnification images highlighted the clusters of PSD95 puncta within the GCL between 
the granule cells, corresponding to mossy and climbing fibers, but the granular cells only 
showed non-specific staining (Figure 5F). A much lower density of PSD95 was detected 
within the neuropil of the MCL, where PSD95 puncta formed a fine linear pattern along 
dendrites (Figure 5G). PSD95 puncta were not present in the white matter (Figure 5H).
The midbrain (Figure 6A-H), pons (Figure 6I-P) and medulla (Figure 6Q-X) were 
examined for PSD95 expression, and overall showed a sparser density of fluorescent 
puncta than the supratentorial structures. Within the midbrain, a low density of PSD95 
puncta was present within the substantia nigra (Figure 6B, D), and a lower density was 
detected in the periaqueductal grey area (Figure 6F, H). The fluorescent signals in these 
areas were moderately bright (Figure 6D, H). Within the pons, moderate density of 
PSD95 puncta was seen in the pontine nuclei (Figure 6J, L) and low density in the locus A
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coeruleus (Figure 6N, PG). The fluorescent signals in these pontine areas were 
moderately bright (Figure 6L, P). Finally, within the medulla, a moderate density of 
PSD95 puncta was present within inferior olivary nucleus (Figure 6R, T), and a low 
density was detected in the hypoglossal nucleus (Figure 6V, X). The PSD95 puncta in 
these medullary areas were dim (Figure 6T, X).
Quantification of PSD95 puncta in human brain regions
To quantify synapses and describe their diversity in the brain regions we used the 
SYNMAP image analysis pipeline created to map the mouse synaptome (Zhu et al., 
2018). Each PSD95 punctum was quantified in terms of its intensity (A.U.) and size 
(μm2). In addition, the density of PSD95 puncta per 100 μm2 was calculated as a mean of 
the number of puncta per region. The mean values for four individuals are shown in 
Figure 7A-C and the data from individual subjects are shown in Figure S4. Figure 7D 
shows a summary of the mean values of each of the puncta parameters on maps of the 
human brain and highlights the diversity of these regions.
Ranking the 20 brain regions shows that the highest synapse density is in the neocortex 
and hippocampal formation and the lowest density in pons, midbrain and brainstem. 
There was an 8.3-fold difference between the highest and lowest mean density in the 
examined areas. Cortical area BA19, a region of the occipital cortex involved with feature 
extraction of visual images, had the highest density of synapses (mean ± SD: 51.74 ± 
11.68) (Figure 7A). Pons had the lowest density of puncta (mean ± SD: 6.26 ± 2.39).
Quantification of PSD95 puncta size across the 20 human brain areas is shown in Figure 
7B. PSD95 puncta size reflects PSD size within an individual synapse (Broadhead et al., 
2016; Zhu et al., 2018). There was a 1.5-fold difference between the smallest and largest 
mean PSD95 puncta size. The secondary visual cortex, area BA19, had the largest 
PSD95 puncta (mean ± SD: 0.28 ± 0.03), whereas midbrain had the smallest (mean ± 
SD: 0.188 ± 0.07).
PSD95 puncta intensity across the 20 human brain areas is shown in Figure 7C. Intensity 
reflects the amount of PSD95 protein in an individual synapse (Broadhead et al., 2016; A
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Zhu et al., 2018). There was a 1.9-fold difference between the highest and the lowest 
mean intensity in the examined areas. The secondary visual cortex, area BA19, showed 
the highest intensity of PSD95 puncta (mean ± SD: 40.6 ± 9.91), whereas medulla 
showed the lowest (mean ± SD: 21.54 ± 2.65). The deep grey nuclei (thalamus and 
caudate nucleus) showed greatest variations between individuals. We quantified the 
synaptic parameters in each of the six layers of 13 neocortical areas and found 
differences between Brodmann areas and between the layers within these areas (Figure 
S5). Together, these data show that PSD95 puncta parameters differ between the 
delineated 20 human brain regions (Figure 7D), with each brain area having a 
characteristic ‘signature’ of these parameters. 
The human PSD95 synaptome architecture is hierarchically organized and similar 
to that of mouse 
With the quantitative synaptic data in hand we could now make comparisons between 
human brain regions. We first examined the similarity of the human brain regions by 
generating a similarity matrix (Figure 8A), which revealed a number of interesting 
patterns. All neocortical areas and hippocampus showed high similarity (with the 
exception of BA19) and these regions were distinct from cerebellum and brainstem 
structures. BA19 is the visual association area and it showed the highest PSD95 density, 
intensity and size. Interestingly, a very similar organization was observed in the mouse 
brain (Zhu et al., 2018). To test if the PSD95 synaptome architecture of the two species 
was conserved we correlated the synaptic puncta parameters between the homologous 
brain regions of the two species and found significant correlations (puncta density, 
r=0.90, p<0.0001; intensity, r=0.51, p=0.05; size, r=0.56, p=0.03) (Figure 8B). We also 
found a significant correlation coefficient (r=0.6,  p= 0.006) between size and density and 
a non-significant correlation coefficient (r=0.4, p=0.08) between size and intensity.
Synaptome architecture can also be analyzed using network methods and in the mouse 
the synaptome shows a small-world network architecture (Zhu et al., 2018). We analyzed 
the synaptome network properties of the 20 human regions: each node in the network 
represented one region and edges that link nodes were scored by similarity of PSD95 
parameters. Three network topological properties, namely clustering coefficient (CC), 
modularity and small-worldness (Figure 8C), were calculated and showed that the PSD95 A
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network has a higher CC and modularity than a random network with equivalent network 
complexity. Thus, the human PSD95 synaptome contains a small-world network structure 
with high small-worldness topology. Together, these findings indicate that the PSD95 
synaptome architecture of the human brain shares core features with that of mouse.
Discussion
Using immunolabelling of PSD95 with high-resolution confocal microscopy and SYNMAP 
image analysis software, we have examined the distribution of excitatory synapses 
across 20 regions of the human brain in four individuals. We found that there are 
populations of PSD95-positive synaptic puncta with different sizes and intensities 
distributed in each brain region. Comparisons of the mean values of the synaptic 
parameters of these populations revealed a hierarchical organisation of the regions, in 
which cortical and hippocampal regions shared greatest similarities, whereas cerebellar 
and brainstem regions had distinct PSD95 synaptome signatures. This is remarkably 
similar to the PSD95 synaptome organisation in the mouse brain (Zhu et al., 2018). 
Moreover, synaptic puncta density, size and intensity correlated between homologous 
brain regions in mouse and human, showing evidence of a conserved synaptome 
architecture. Furthermore, the PSD95 synaptome architecture of both species showed 
small-world network properties. These data indicate that the synaptome architecture of 
PSD95-positive excitatory synapses retains invariant features during the 90 million years 
since humans and mice shared a common ancestor and despite the 1000-fold difference 
in brain size. Previous studies have shown that the synapse proteome composition is 
highly conserved between mouse and human (Bayes et al., 2011; Bayes et al., 2012) and 
that regional diversity in the postsynaptic proteome of the human cortex (Roy et al., 
2018b) and mouse brain shows similar features (Roy et al., 2018a). Thus, the molecular 
anatomy of synapse protein composition, synapse diversity and its spatial organization 
exhibit conserved features between humans and mice.
The present study has a number of limitations. Synapse labelling has been restricted to a 
single postsynaptic marker of excitatory synapses and as such represents a first step in 
the task of mapping the human brain synaptome. PSD95 will not, for example, have 
reported on the diversity of inhibitory synapses. Combining PSD95 labelling with other A
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synaptic markers enables sub-categorisation of excitatory synapses (Zhu et al., 2018). 
Electron microscopy and super-resolution nanoscopy reveal morphological differences in 
synapses that escape detection with confocal microscopy (Broadhead et al., 2016; 
Masch et al., 2018) and future studies combining these forms of microscopy will be 
required for the most comprehensive analyses.  A further limitation of this study is that we 
have not created a fine-scaled PSD95 synaptome map of all the subregions within the 20 
regions we have studied. This will require more extensive microscopy, scanning larger 
areas of brain tissue. We are currently designing experiments and developing technical 
approaches suitable for mapping all grey matter regions in whole coronal sections of 
human brain, which is a step toward a brain-wide synaptome atlas of the human.
Post-mortem delay (PMD) could lead to artefacts in the labelling and quantification of 
synapse proteins using single-synapse resolution methods. Biochemical studies show 
that human synaptic proteins vary in their rate of degradation with PMD, with PSD95 
being relatively stable for at least 24 hours (Siew et al., 2004; Bayes et al., 2014; Sinclair 
et al., 2015). To minimize the effects of PMD, we pre-screened our brain samples using a 
biochemical assay that measures the integrity of synaptic proteins and selected samples 
that did not show degradation (Bayes et al., 2014). The image analysis methods we 
describe in the current study can now be used to examine the impact of PMD on PSD95 
puncta parameters.
As high synapse diversity arises from the differential distribution of synaptic proteins and 
their cognate multiprotein complexes (Grant, 2018; Zhu et al., 2018; Grant, 2019), it is 
likely that a detailed characterization of the synaptome of diverse molecular types of 
synapses in humans and mice could reveal species-specific differences. Understanding 
these differences could be extremely important for translational studies from the mouse. 
Mice carrying mutations in human orthologs that cause schizophrenia and autism have 
been shown to have altered synapse diversity and synaptome maps (Zhu et al., 2018; 
Grant, 2019). The availability of synaptomic methods in humans provides an opportunity 
to identify synaptic pathology in human brain diseases. The availability of a human 
synaptome atlas for multiple synapse types and comparable atlases in other mammalian A
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species will inform on the function of the human brain and the basis of behaviour in 
health and disease.
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CB, Cerebellum
CN, Caudate Nucleus
CNXII, Hypoglossal Cranial Nerve
DG, Dentate Gyrus
DG-PL, DG-Polymorphic Layer
DG-SG, DG-Stratum Granulosum
DG-SM, DG-Stratum Moleculare
EBB, Edinburgh Brain Bank
FFPE, formalin-fixed paraffin-embedded
GCL, Granular cell layer
HC, Hippocampus
IHC, immunohistochemistry
ION, Inferior Olivary Nucleus
LC, Locus Ceruleus
LSCM, Laser Scanning Confocal Microscope
MB, Midbrain
MCL, Molecular cell layer
MD, Medulla
PC, Purkinje cell
PN, Pontine nuclei
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PSD, postsynaptic density
SN, Substantia Nigra
TH, Thalamus
WM, White matter
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TABLE 1 Details of the human control subjects used in this study. 
 
Case ID SD23/13 SD25/13 SD32/13 SD42/13 
Age (y) 53 47 61 46 
Gender Male Male Male Female 
Height (m) 1.75 1.83 1.68 1.68 
Weight (kg) 112 105 63 102 
BMI 36.6 31.4 22.3 36.1 
Hx of 
dementia 
no no no no 
Smoking no yes no yes 
Medication no no yes yes 
   Bendrofluazide Simvastatin 
   Amlodipine Bisoprolol 
   Diffundox Lisinopril 
Significant 
PMH 
Depression nil nil Hypertension 
    Hyperlipidaemia 
Cause of 
death 
CAT CAA HPC MI 
Abbreviations: 
CAT – Coronary artery thrombosis  
CAA – Coronary artery atherosclerosis  
HPC – Hemopericardium  
MI – Myocardial infarction  
BMI – Body mass index   
Hx of dementia – History of dementia  
PMH – Past medical history   
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TABLE 2 Neuropathological assessment of human tissue used in this study.  
 
Case ID SD23/13 SD25/13 SD32/13 SD42/13 
Brain weight 
(g) 
1650 1690 1270 1210 
PMD (h) 103 31 99 27 
pH 6.1 6.5 6.2 6.5 
RIN 5.65 5.30 6.15 4.90 
APOE  3/4 3/3 3/4 3/3 
HUSPIR 3.75 2.52 3.94 1.83 
Thal Aβ 0 0 2 0 
Braak NFT 0 0 I 0 
CERAD 0 0 I 0 
CAA 0 0 0 0 
Abbreviations:  
PMD – post-mortem delay  
RIN – RNA integrity number 
APOE – apolipoprotein E; the APOE genotypes and HUSPIRs were performed on 
area BA41/42  
HUSPIR - Human synaptic protein integrity ratio  
Aβ – Beta amyloid  
NFT – Neurofibrillary tangles   
CERAD – Consortium to Establish a Registry for Alzheimer’s Disease  
CAA – Cerebral amyloid angiopathy  
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TABLE 3 Human brain areas analysed in this study. 
 
Neocortex 1 Motor cortex (BA4) -layers (I-VI) 
 2 Premotor cortex (BA6/8) -layers (I-VI) 
 3 Dorsolateral prefrontal (BA9) -layers (I-VI) 
 4 Orbitofrontal (BA11/12) -layers (I-VI) 
 5 Occipital (BA17) -layers (I-VI) 
 6 Occipital (BA19) -layers (I-VI) 
 7 Inferior temporal (BA20/21) -layers (I-VI) 
 8 Occipitotemporal (BA37) -layers (I-VI) 
 9 Temporal polar (BA38) -layers (I-VI) 
 10 Inferior parietal (BA39) -layers (I-VI) 
 11 Superior temporal (BA41/42) -layers (I-VI) 
 12 Ventrolateral prefrontal (BA44/45) -layers (I-VI) 
 13 Dorsolateral prefrontal (BA46) -layers (I-VI) 
Allocortex 14 Hippocampus (HC) -Cornu ammonis 1 
(CA1) 
   -Cornu ammonis 2 
(CA2) 
   -Cornu ammonis 3 
(CA3) 
   -Cornu ammonis 4 
(CA4) 
   -Dentate gyrus (DG) 
Subcortical 
grey nuclei 
15 Thalamus (TH)  
 16 Caudate nucleus (CN)  
Cerebellum 17 Cerebellum (CB) -Granular cell layer  
(GL) 
   -Molecular cell layer 
(ML) 
Brainstem  18 Midbrain (MB) -Periaqueductal grey 
(PAG) A
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   -Substantia nigra  
(SN) 
 19 Pons (PO) -Locus coeruleus  
(LC) 
   -Pontine nuclei  
(PN) 
 20 Medulla (MD) -Inferior olivary nucleus 
(ION) 
   -Hypoglossal nerve 
(CNXII) 
Abbreviations:  
BA – Brodmann area 
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Figure Legends 
 
Figure 1. Comparison of PSD95 expression between human and mouse brain.  
Similarity of PSD95 labelling patterns between human and mouse. 
Panels in green: tissue from mutant knock-in mouse examined using direct 
fluorescence microscopy of PSD-EGFP fusion protein in the adult Psd95EGFP/+ 
heterozygote.  
Panels in magenta: human tissue stained with PSD95 antibody using indirect 
immunofluorescence. 
Similar patterns of staining were observed in human and mouse cortex (A-D), 
thalamus (I-L), cerebellar granular (M-P) and molecular (Q-T) cell layers. Similar 
patterns of staining were also observed in the hippocampal CA3 region, although the 
staining was present in two different subregions: in mouse in stratum lucidum (E, F), 
but in human in stratum pyramidale (G, H). 
Scale bars: 20 μm in A, E, I, M, Q; 2 μm in B, J, N, R; 5 μm in F; 30 μm in C, G, S; 100 
μm in K, O; 10 μm in D, H, L, P, T. 
 
Figure 2. PSD95 expression in 20 human brain regions.  
Representative images from 20 human brain regions showing the different patterns of 
PSD95 distribution detected by immunofluorescence. Similar patterns of staining were 
observed in human and mouse cortex (A-D), thalamus (I-L), cerebellar granular (M-P) 
and molecular (Q-T) cell layers. Similar patterns of staining were also observed in the 
hippocampal CA3 region, although the staining was present in two different 
subregions: in mouse in stratum lucidum (E, F), but in human in stratum pyramidale 
(G, H).  
BA, Brodmann area; TH, thalamus; CN, caudate nucleus; HC, hippocampus; CA, 
cornu ammonis; slm, stratum lacunosum – moleculare; sp, stratum pyramidale; DG 
sm, dentate gyrus stratum moleculare; CB, cerebellum; GCL, granular cell layer; MCL, 
molecular cell layer; MB, midbrain; PO, pons; MD, medulla. Scale bar: 10 μm. 
 
Figure 3. PSD95 staining in the human hippocampus.  
(A) Nissl-stained section assessing hippocampal neuroanatomy.  
(B) PSD95 labelling in the hippocampus, subiculum and adjacent parahippocampal 
gyrus.  
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(C) Negative control stained without primary antibody showing absence of PSD95 
signal.  
(D) PSD95 labelling, (E) PSD95 with DAPI, and (F) negative control with DAPI in the 
hippocampus proper. 
(G) PSD95 labelling in the CA2 subregion.  
(H) PSD95 labelling in the DG subregion.  
(I) PSD95 labelling with DAPI, and negative control (J) in the CA2 subregion.  
(K) PSD95 labelling with DAPI, and negative control (L) in the DG subregion.  
(M-P) PSD95 staining in the indicated hippocampal subregions.  
HC, hippocampus; Sub, subiculum; PHG, parahippocampal gyrus; DG, dentate gyrus; 
DG-ML, DG-molecular layer; DG-PL, DG-pleomorphic layer; DG-GL, DG-granule cell 
layer; SR, stratum radiatum; SO, stratum oriens; SLM, stratum lacunosum-moleculare. 
Scale bars: (A-F) 2 mm, (G-L) 200 μm, (M-P) 10 μm. 
 
Figure 4. PSD95 staining in the human caudate nucleus and thalamus. 
(A-F) Caudate nucleus 
(A) Nissl-stained section to assess neuroanatomy of the caudate nucleus. 
(B) PSD95 staining was not homogenous, as small darker patches of striosomes were 
identified scattered within the caudate matrix (asterisk). 
(C) Omission of PSD95 primary antibody showed a lack of PSD95 labelling. 
(D) PSD95 puncta within a striosome (arrowheads) and a matrix. Somatic staining of 
PSD95 in medium spiny neurons was present in addition to dendritic PSD95 puncta.  
(E) The same striosome visualized with Calbindin-D28K antibody.  
(F) Merged image showing PSD95 and Calbindin-D28K labelling. 
(G-J) Thalamus 
(G) Nissl-stained section to assess thalamic neuroanatomy. 
(H) PSD95 labelling was variable, but prominent throughout the thalamus. 
(I) Omission of PSD95 primary antibody showed lack of PSD95 expression. 
(J) Punctate PSD95 staining along dendrites (arrowheads) within the thalamus. 
Scale bars: (A-C, G-I) 2 mm, (D-F) 100 μm, (J) 10 μm. 
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Figure 5. PSD95 staining in the human cerebellum.  
(A) Nissl-stained section assessing cerebellar neuroanatomy: cerebellar cortex (folia), 
WM and the DN.  
(B) PSD95 labelling in the cerebellar folia, WM and the DN.  
(C) DAPI with negative control stained without primary antibody showing absence of 
PSD95 staining. 
(D) Numerous and dense clusters of PSD95 puncta dispersed throughout the 
glomerular region of the GCL between the granule cells (short arrowheads). PSD95 
puncta were detected in the terminal pinceau of cerebellar basket cells, but PC 
neurons did not express PSD95 (long arrowheads). In MCL, PSD95 was observed as 
fine linear pattern with strong labelling of stellate and basket cell nuclei (asterisks).  
(E) PSD95 staining abolished in a negative control section, showing lack of staining 
around and within PCs (arrowheads).  
(F) PSD95 staining in the GCL showing numerous intense puncta within the clusters. 
Arrowheads point to areas of rosette-like punctate formations.  
(G) PSD95 staining within MCL localized along dendrites.  
(H) No punctate PSD95 labelling was present in the cerebellar white matter.  
WM, white matter; DN, dentate nucleus; PC, Purkinje cell; GCL, granular cell layer; 
MCL, molecular cell layer. Scale bars: (A-C) 2 mm, (D, E) 100 μm, (F-H) 10 μm. 
 
Figure 6. Pattern of PSD95 staining in the human brainstem.  
(A-H) Midbrain 
Nissl-stained sections of the SN (A) and PAG (E) within the midbrain. 
PSD95 staining within the SN (B) and PAG (F) was of low density. PSD95 labelling 
was absent from large pigmented neurons of the SN (B, asterisk). 
No PSD95 expression was detected in the SN (C) or PAG (G) in the negative controls 
without primary antibody. 
Sparse density of PSD95 puncta in SN (D) and PAG (H). 
(I-P) Pons 
Nissl-stained sections of the PN (I) and LC (M) in the pons. 
PSD95 staining within the PN (J) was low, but higher than in the LC (N).  
No PSD95 expression was detected in the PN (K) or LC (O) in the negative controls. 
Low density of PSD95 puncta in the PN (L), and sparse density within LC (P). 
(Q-X) Medulla 
This article is protected by copyright. All rights reserved 
  
Nissl-stained sections of the ION (Q) and CNXII (U) within the medulla. 
PSD95 staining within the ION (R) was low, but higher than in the CNXII (V).  
Negative controls confirmed no PSD95 expression within the ION (S) and CNXII (W). 
Low density of PSD95 puncta in the ION (T) and sparse density within CNXII (X). 
CA, cerebral aqueduct; PAG, periaqueductal grey; SN, substantia nigra; PN, pontine 
nuclei; LC, locus coeruleus; ION, inferior olivary nucleus; CNXII, nucleus of the cranial 
nerve XII (hypoglossal nucleus). 
Scale bars: 100 μm, except (D, H, L, P, T, X) 10 μm. 
 
Figure 7. Quantification of PSD95 in 20 human brain areas.  
 
(A-C) Boxplots showing quantification of PSD95 puncta density (per 100 μm2) (A), size 
(μm2) (B) and intensity (a.u.) (C) in 20 human brain areas from four control cases.  (D) 
Colour-coded PSD95 synaptome map based on quantifications of parameters.  
BA, Brodmann area; HC, hippocampus; TH, thalamus; CN, caudate nucleus; CB, 
cerebellum; MB, midbrain, PO, pons; MD, medulla.   
 
Figure 8. Mapping of PSD95 at whole brain scale. 
(A) Similarity matrix between pairs of the 20 human brain regions examined (rows and 
columns).  
(B) Correlation of PSD95 puncta parameters between human and mouse. Scatterplots 
show correlations of PSD95 immunofluorescent puncta parameters (density, intensity 
and size) quantified from 15 brain areas of PSD95-EGFP knock-in mouse and human 
tissue stained using PSD95 antibody. A moderate positive, linear and significant 
correlation was found for both PSD95 puncta intensity and puncta size between the 
two species. Pearson’s product-moment correlation (r) and p values are provided, 
based on three male WT mice aged 12 months and three male human controls.  
(C) PSD95 network topology. Clustering coefficient, modularity, and small-worldness 
of the PSD95 network and random network. 
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